Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Pancreatic Neoplasms 8Breast Neoplasms 5Thyroid Nodule 3Thyroid Neoplasms 3Lymphoma 3Gastrointestinal Stromal Tumors 2Disease 2Sarcoidosis 1Pancreatitis, Chronic 1Neoplastic Cells, Circulating 1Neoplasm Metastasis 1Melanoma 1Lymphadenopathy 1Lung Neoplasms 1Head and Neck Neoplasms 1Focus: Breast Cancer With Axillary Node Metastasis 1Bile Duct Neoplasms 1

Interventions

Radiosurgery 23Magnetic Resonance Spectroscopy 13Radiotherapy 9Cryosurgery 9Blood Specimen Collection 9Standard of Care 8Surveys and Questionnaires 7Educational Status 7Surgical Procedures, Operative 6Drug Therapy 6Radiotherapy, Intensity-Modulated 5Palliative Care 5Methods 5Radiofrequency Ablation 4Practice Guidelines as Topic 4Everolimus 4Early Intervention, Educational 4Interviews as Topic 3Exercise Therapy 3Cryotherapy 3Androgen Antagonists 3Zoledronic Acid 2Videotape Recording 2Trastuzumab 2Radiation 2Physical Therapy Modalities 2Patient Navigation 2Misoprostol 2Manual Lymphatic Drainage 2Liver Transplantation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Neoplasm Metastasis × Biopsy, Fine-Needle × Clear all
NCT01048099 2016-01-29

Use of PRO Onc Assay to Assess HER2 in Patients With Metastatic Breast Cancer

SCRI Development Innovations, LLC

Phase NA Completed
283 enrolled 8 charts
Breast

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡